Global Celecoxib Market Research Report 2020


This report focuses on Celecoxib volume and value at global level, regional level and company level. From a global perspective, this report represents overall Celecoxib market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
    Pfizer
    Takeda
    Teva
    Mylan
    Chengdu Suncadia Pharmaceuticals
    Jiangsu Chiatai Qingjiang Pharmaceutical
    Anhui Heyi Chemical
    ...

Segment by Regions
    North America
    Europe
    China
    Japan

Segment by Type
    50mg Celecoxib
    100mg Celecoxib
    200mg Celecoxib
    400mg Celecoxib

Segment by Application
    Rheumatoid Arthritis
    Osteoarthritis
    Acute Pain
    Musculoskeletal Pain
    Others
Table of Contents

1 Celecoxib Market Overview
    1.1 Product Overview and Scope of Celecoxib
    1.2 Celecoxib Segment by Type
        1.2.1 Global Celecoxib Sales Growth Rate Comparison by Type (2021-2026)
        1.2.2 50mg Celecoxib
        1.2.3 100mg Celecoxib
        1.2.4 200mg Celecoxib
        1.2.5 400mg Celecoxib
    1.3 Celecoxib Segment by Application
        1.3.1 Celecoxib Sales Comparison by Application: 2020 VS 2026
        1.3.2 Rheumatoid Arthritis
        1.3.3 Osteoarthritis
        1.3.4 Acute Pain
        1.3.5 Musculoskeletal Pain
        1.3.6 Others
    1.4 Global Celecoxib Market Size Estimates and Forecasts
        1.4.1 Global Celecoxib Revenue 2015-2026
        1.4.2 Global Celecoxib Sales 2015-2026
        1.4.3 Celecoxib Market Size by Region: 2020 Versus 2026

2 Global Celecoxib Market Competition by Manufacturers
    2.1 Global Celecoxib Sales Market Share by Manufacturers (2015-2020)
    2.2 Global Celecoxib Revenue Share by Manufacturers (2015-2020)
    2.3 Global Celecoxib Average Price by Manufacturers (2015-2020)
    2.4 Manufacturers Celecoxib Manufacturing Sites, Area Served, Product Type
    2.5 Celecoxib Market Competitive Situation and Trends
        2.5.1 Celecoxib Market Concentration Rate
        2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
        2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
    2.7 Primary Interviews with Key Celecoxib Players (Opinion Leaders)

3 Celecoxib Retrospective Market Scenario by Region
    3.1 Global Celecoxib Retrospective Market Scenario in Sales by Region: 2015-2020
    3.2 Global Celecoxib Retrospective Market Scenario in Revenue by Region: 2015-2020
    3.3 North America Celecoxib Market Facts & Figures by Country
        3.3.1 North America Celecoxib Sales by Country
        3.3.2 North America Celecoxib Sales by Country
        3.3.3 U.S.
        3.3.4 Canada
    3.4 Europe Celecoxib Market Facts & Figures by Country
        3.4.1 Europe Celecoxib Sales by Country
        3.4.2 Europe Celecoxib Sales by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Celecoxib Market Facts & Figures by Region
        3.5.1 Asia Pacific Celecoxib Sales by Region
        3.5.2 Asia Pacific Celecoxib Sales by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
        3.5.12 Philippines
        3.5.13 Vietnam
    3.6 Latin America Celecoxib Market Facts & Figures by Country
        3.6.1 Latin America Celecoxib Sales by Country
        3.6.2 Latin America Celecoxib Sales by Country
        3.6.3 Mexico
        3.6.3 Brazil
        3.6.3 Argentina
    3.7 Middle East and Africa Celecoxib Market Facts & Figures by Country
        3.7.1 Middle East and Africa Celecoxib Sales by Country
        3.7.2 Middle East and Africa Celecoxib Sales by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 U.A.E
4 Global Celecoxib Historic Market Analysis by Type
    4.1 Global Celecoxib Sales Market Share by Type (2015-2020)
    4.2 Global Celecoxib Revenue Market Share by Type (2015-2020)
    4.3 Global Celecoxib Price Market Share by Type (2015-2020)
    4.4 Global Celecoxib Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Global Celecoxib Historic Market Analysis by Application
    5.1 Global Celecoxib Sales Market Share by Application (2015-2020)
    5.2 Global Celecoxib Revenue Market Share by Application (2015-2020)
    5.3 Global Celecoxib Price by Application (2015-2020)

6 Company Profiles and Key Figures in Celecoxib Business
    6.1 Pfizer
        6.1.1 Corporation Information
        6.1.2 Pfizer Description, Business Overview and Total Revenue
        6.1.3 Pfizer Celecoxib Sales, Revenue and Gross Margin (2015-2020)
        6.1.4 Pfizer Products Offered
        6.1.5 Pfizer Recent Development
    6.2 Takeda
        6.2.1 Takeda Celecoxib Production Sites and Area Served
        6.2.2 Takeda Description, Business Overview and Total Revenue
        6.2.3 Takeda Celecoxib Sales, Revenue and Gross Margin (2015-2020)
        6.2.4 Takeda Products Offered
        6.2.5 Takeda Recent Development
    6.3 Teva
        6.3.1 Teva Celecoxib Production Sites and Area Served
        6.3.2 Teva Description, Business Overview and Total Revenue
        6.3.3 Teva Celecoxib Sales, Revenue and Gross Margin (2015-2020)
        6.3.4 Teva Products Offered
        6.3.5 Teva Recent Development
    6.4 Mylan
        6.4.1 Mylan Celecoxib Production Sites and Area Served
        6.4.2 Mylan Description, Business Overview and Total Revenue
        6.4.3 Mylan Celecoxib Sales, Revenue and Gross Margin (2015-2020)
        6.4.4 Mylan Products Offered
        6.4.5 Mylan Recent Development
    6.5 Chengdu Suncadia Pharmaceuticals
        6.5.1 Chengdu Suncadia Pharmaceuticals Celecoxib Production Sites and Area Served
        6.5.2 Chengdu Suncadia Pharmaceuticals Description, Business Overview and Total Revenue
        6.5.3 Chengdu Suncadia Pharmaceuticals Celecoxib Sales, Revenue and Gross Margin (2015-2020)
        6.5.4 Chengdu Suncadia Pharmaceuticals Products Offered
        6.5.5 Chengdu Suncadia Pharmaceuticals Recent Development
    6.6 Jiangsu Chiatai Qingjiang Pharmaceutical
        6.6.1 Jiangsu Chiatai Qingjiang Pharmaceutical Celecoxib Production Sites and Area Served
        6.6.2 Jiangsu Chiatai Qingjiang Pharmaceutical Description, Business Overview and Total Revenue
        6.6.3 Jiangsu Chiatai Qingjiang Pharmaceutical Celecoxib Sales, Revenue and Gross Margin (2015-2020)
        6.6.4 Jiangsu Chiatai Qingjiang Pharmaceutical Products Offered
        6.6.5 Jiangsu Chiatai Qingjiang Pharmaceutical Recent Development
    6.7 Anhui Heyi Chemical
        6.6.1 Anhui Heyi Chemical Celecoxib Production Sites and Area Served
        6.6.2 Anhui Heyi Chemical Description, Business Overview and Total Revenue
        6.6.3 Anhui Heyi Chemical Celecoxib Sales, Revenue and Gross Margin (2015-2020)
        6.4.4 Anhui Heyi Chemical Products Offered
        6.7.5 Anhui Heyi Chemical Recent Development

7 Celecoxib Manufacturing Cost Analysis
    7.1 Celecoxib Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Raw Materials Price Trend
       7.1.3 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Celecoxib
    7.4 Celecoxib Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Celecoxib Distributors List
    8.3 Celecoxib Customers

9 Market Dynamics
    9.1 Market Trends
    9.2 Opportunities and Drivers
    9.3 Challenges
    9.4 Porter's Five Forces Analysis

10 Global Market Forecast
    10.1 Global Celecoxib Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Celecoxib by Type (2021-2026)
        10.1.2 Global Forecasted Revenue of Celecoxib by Type (2021-2026)
    10.2 Celecoxib Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Celecoxib by Application (2021-2026)
        10.2.2 Global Forecasted Revenue of Celecoxib by Application (2021-2026)
    10.3 Celecoxib Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Celecoxib by Region (2021-2026)
        10.3.2 Global Forecasted Revenue of Celecoxib by Region (2021-2026)
    10.4 North America Celecoxib Estimates and Projections (2021-2026)
    10.5 Europe Celecoxib Estimates and Projections (2021-2026)
    10.6 Asia Pacific Celecoxib Estimates and Projections (2021-2026)
    10.7 Latin America Celecoxib Estimates and Projections (2021-2026)
    10.8 Middle East and Africa Celecoxib Estimates and Projections (2021-2026)
11 Research Finding and Conclusion

12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Tables Table 1. Global Celecoxib Sales (K MT) Growth Rate Comparison by Type (2015-2026) Table 2. Global Celecoxib Sales (K MT) Comparison by Application: 2020 VS 2026 Table 3. Global Celecoxib Market Size by Type (K MT) (US$ Million) (2020 VS 2026) Table 4. Global Key Celecoxib Manufacturers Covered in This Study Table 5. Global Celecoxib Sales (K MT) by Manufacturers (2015-2020) Table 6. Global Celecoxib Sales Share by Manufacturers (2015-2020) Table 7. Global Celecoxib Revenue (Million USD) by Manufacturers (2015-2020) Table 8. Global Celecoxib Revenue Share by Manufacturers (2015-2020) Table 9. Global Market Celecoxib Average Price (USD/MT) of Key Manufacturers (2015-2020) Table 10. Manufacturers Celecoxib Sales Sites and Area Served Table 11. Manufacturers Celecoxib Product Types Table 12. Global Celecoxib Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Celecoxib by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Celecoxib as of 2019) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Main Points Interviewed from Key Celecoxib Players Table 16. Global Celecoxib Sales (K MT) by Region (2015-2020) Table 17. Global Celecoxib Sales Market Share by Region (2015-2020) Table 18. Global Celecoxib Revenue (Million US$) by Region (2015-2020) Table 19. Global Celecoxib Revenue Market Share by Region (2015-2020) Table 20. North America Celecoxib Sales by Country (2015-2020) (K MT) Table 21. North America Celecoxib Sales Market Share by Country (2015-2020) Table 22. North America Celecoxib Revenue by Country (2015-2020) (US$ Million) Table 23. North America Celecoxib Revenue Market Share by Country (2015-2020) Table 24. Europe Celecoxib Sales by Country (2015-2020) (K MT) Table 25. Europe Celecoxib Sales Market Share by Country (2015-2020) Table 26. Europe Celecoxib Revenue by Country (2015-2020) (US$ Million) Table 27. Europe Celecoxib Revenue Market Share by Country (2015-2020) Table 28. Asia Pacific Celecoxib Sales by Region (2015-2020) (K MT) Table 29. Asia Pacific Celecoxib Sales Market Share by Region (2015-2020) Table 30. Asia Pacific Celecoxib Revenue by Region (2015-2020) (US$ Million) Table 31. Asia Pacific Celecoxib Revenue Market Share by Region (2015-2020) Table 32. Latin America Celecoxib Sales by Country (2015-2020) (K MT) Table 33. Latin America Celecoxib Sales Market Share by Country (2015-2020) Table 34. Latin America Celecoxib Revenue by Country (2015-2020) (US$ Million) Table 35. Latin America Celecoxib Revenue Market Share by Country (2015-2020) Table 36. Middle East and Africa Celecoxib Sales by Country (2015-2020) (K MT) Table 37. Middle East and Africa Celecoxib Sales Market Share by Country (2015-2020) Table 38. Middle East and Africa Celecoxib Revenue by Country (2015-2020) (US$ Million) Table 39. Middle East and Africa Celecoxib Revenue Market Share by Country (2015-2020) Table 40. Global Celecoxib Sales (K MT) by Type (2015-2020) Table 41. Global Celecoxib Sales Share by Type (2015-2020) Table 42. Global Celecoxib Revenue (Million US$) by Type (2015-2020) Table 43. Global Celecoxib Revenue Share by Type (2015-2020) Table 44. Global Celecoxib Price (USD/MT) by Type (2015-2020) Table 45. Global Celecoxib Sales (K MT) by Application (2015-2020) Table 46. Global Celecoxib Sales Market Share by Application (2015-2020) Table 47. Global Celecoxib Sales Growth Rate by Application (2015-2020) Table 48. Pfizer Celecoxib Corporation Information Table 49. Pfizer Description and Business Overview Table 50. Pfizer Celecoxib Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 51. Pfizer Main Product Table 52. Pfizer Recent Development Table 53. Takeda Celecoxib Corporation Information Table 54. Takeda Corporation Information Table 55. Takeda Celecoxib Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 56. Takeda Main Product Table 57. Takeda Recent Development Table 58. Teva Celecoxib Corporation Information Table 59. Teva Corporation Information Table 60. Teva Celecoxib Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 61. Teva Main Product Table 62. Teva Recent Development Table 63. Mylan Celecoxib Corporation Information Table 64. Mylan Corporation Information Table 65. Mylan Celecoxib Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 66. Mylan Main Product Table 67. Mylan Recent Development Table 68. Chengdu Suncadia Pharmaceuticals Celecoxib Corporation Information Table 69. Chengdu Suncadia Pharmaceuticals Corporation Information Table 70. Chengdu Suncadia Pharmaceuticals Celecoxib Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 71. Chengdu Suncadia Pharmaceuticals Main Product Table 72. Chengdu Suncadia Pharmaceuticals Recent Development Table 73. Jiangsu Chiatai Qingjiang Pharmaceutical Celecoxib Corporation Information Table 74. Jiangsu Chiatai Qingjiang Pharmaceutical Corporation Information Table 75. Jiangsu Chiatai Qingjiang Pharmaceutical Celecoxib Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 76. Jiangsu Chiatai Qingjiang Pharmaceutical Main Product Table 77. Jiangsu Chiatai Qingjiang Pharmaceutical Recent Development Table 78. Anhui Heyi Chemical Celecoxib Corporation Information Table 79. Anhui Heyi Chemical Corporation Information Table 80. Anhui Heyi Chemical Celecoxib Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 81. Anhui Heyi Chemical Main Product Table 82. Anhui Heyi Chemical Recent Development Table 83. Sales Base and Market Concentration Rate of Raw Material Table 84. Key Suppliers of Raw Materials Table 85. Celecoxib Distributors List Table 86. Celecoxib Customers List Table 87. Market Key Trends Table 88. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 89. Key Challenges Table 90. Global Celecoxib Sales (K MT) Forecast by Type (2021-2026) Table 91. Global Celecoxib Sales Market Share Forecast by Type (2021-2026) Table 92. Global Celecoxib Revenue (Million US$) Forecast by Type (2021-2026) Table 93. Global Celecoxib Revenue (Million US$) Market Share Forecast by Type (2021-2026) Table 94. Global Celecoxib Sales (K MT) Forecast by Application (2021-2026) Table 95. Global Celecoxib Revenue (Million US$) Forecast by Application (2021-2026) Table 96. Global Celecoxib Sales (K MT) Forecast by Region (2021-2026) Table 97. Global Celecoxib Sales Market Share Forecast by Region (2021-2026) Table 98. Global Celecoxib Revenue Forecast by Region (2021-2026) (US$ Million) Table 99. Global Celecoxib Revenue Market Share Forecast by Region (2021-2026) Table 100. Research Programs/Design for This Report Table 101. Key Data Information from Secondary Sources Table 102. Key Data Information from Primary Sources List of Figures Figure 1. Picture of Celecoxib Figure 2. Global Celecoxib Sales Market Share by Type: 2020 VS 2026 Figure 3. 50mg Celecoxib Product Picture Figure 4. 100mg Celecoxib Product Picture Figure 5. 200mg Celecoxib Product Picture Figure 6. 400mg Celecoxib Product Picture Figure 7. Global Celecoxib Consumption Market Share by Application: 2020 VS 2026 Figure 8. Rheumatoid Arthritis Figure 9. Osteoarthritis Figure 10. Acute Pain Figure 11. Musculoskeletal Pain Figure 12. Others Figure 13. Global Celecoxib Market Size 2015-2026 (US$ Million) Figure 14. Global Celecoxib Sales Capacity (K MT) (2015-2026) Figure 15. Global Celecoxib Market Size Market Share by Region: 2020 Versus 2026 Figure 16. Celecoxib Sales Share by Manufacturers in 2020 Figure 17. Global Celecoxib Revenue Share by Manufacturers in 2019 Figure 18. The Global 5 and 10 Largest Players: Market Share by Celecoxib Revenue in 2019 Figure 19. Celecoxib Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 20. Global Celecoxib Sales Market Share by Region (2015-2020) Figure 21. Global Celecoxib Sales Market Share by Region in 2019 Figure 22. Global Celecoxib Revenue Market Share by Region (2015-2020) Figure 23. Global Celecoxib Revenue Market Share by Region in 2019 Figure 24. North America Celecoxib Sales Market Share by Country in 2019 Figure 25. North America Celecoxib Revenue Market Share by Country in 2019 Figure 26. U.S. Celecoxib Sales Growth Rate (2015-2020) (K MT) Figure 27. U.S. Celecoxib Revenue Growth Rate (2015-2020) (US$ Million) Figure 28. Canada Celecoxib Sales Growth Rate (2015-2020) (K MT) Figure 29. Canada Celecoxib Revenue Growth Rate (2015-2020) (US$ Million) Figure 30. Europe Celecoxib Sales Market Share by Country in 2019 Figure 31. Europe Celecoxib Revenue Market Share by Country in 2019 Figure 32. Germany Celecoxib Sales Growth Rate (2015-2020) (K MT) Figure 33. Germany Celecoxib Revenue Growth Rate (2015-2020) (US$ Million) Figure 34. France Celecoxib Sales Growth Rate (2015-2020) (K MT) Figure 35. France Celecoxib Revenue Growth Rate (2015-2020) (US$ Million) Figure 36. U.K. Celecoxib Sales Growth Rate (2015-2020) (K MT) Figure 37. U.K. Celecoxib Revenue Growth Rate (2015-2020) (US$ Million) Figure 38. Italy Celecoxib Sales Growth Rate (2015-2020) (K MT) Figure 39. Italy Celecoxib Revenue Growth Rate (2015-2020) (US$ Million) Figure 40. Russia Celecoxib Sales Growth Rate (2015-2020) (K MT) Figure 41. Russia Celecoxib Revenue Growth Rate (2015-2020) (US$ Million) Figure 42. Asia Pacific Celecoxib Sales Market Share by Region in 2019 Figure 43. Asia Pacific Celecoxib Revenue Market Share by Region in 2019 Figure 44. China Celecoxib Sales Growth Rate (2015-2020) (K MT) Figure 45. China Celecoxib Revenue Growth Rate (2015-2020) (US$ Million) Figure 46. Japan Celecoxib Sales Growth Rate (2015-2020) (K MT) Figure 47. Japan Celecoxib Revenue Growth Rate (2015-2020) (US$ Million) Figure 48. South Korea Celecoxib Sales Growth Rate (2015-2020) (K MT) Figure 49. South Korea Celecoxib Revenue Growth Rate (2015-2020) (US$ Million) Figure 50. India Celecoxib Sales Growth Rate (2015-2020) (K MT) Figure 51. India Celecoxib Revenue Growth Rate (2015-2020) (US$ Million) Figure 52. Australia Celecoxib Sales Growth Rate (2015-2020) (K MT) Figure 53. Australia Celecoxib Revenue Growth Rate (2015-2020) (US$ Million) Figure 54. Taiwan Celecoxib Sales Growth Rate (2015-2020) (K MT) Figure 55. Taiwan Celecoxib Revenue Growth Rate (2015-2020) (US$ Million) Figure 56. Indonesia Celecoxib Sales Growth Rate (2015-2020) (K MT) Figure 57. Indonesia Celecoxib Revenue Growth Rate (2015-2020) (US$ Million) Figure 58. Thailand Celecoxib Sales Growth Rate (2015-2020) (K MT) Figure 59. Thailand Celecoxib Revenue Growth Rate (2015-2020) (US$ Million) Figure 60. Malaysia Celecoxib Sales Growth Rate (2015-2020) (K MT) Figure 61. Malaysia Celecoxib Revenue Growth Rate (2015-2020) (US$ Million) Figure 62. Philippines Celecoxib Sales Growth Rate (2015-2020) (K MT) Figure 63. Philippines Celecoxib Revenue Growth Rate (2015-2020) (US$ Million) Figure 64. Vietnam Celecoxib Sales Growth Rate (2015-2020) (K MT) Figure 65. Vietnam Celecoxib Revenue Growth Rate (2015-2020) (US$ Million) Figure 66. Latin America Celecoxib Sales Market Share by Country in 2019 Figure 67. Latin America Celecoxib Revenue Market Share by Country in 2019 Figure 68. Mexico Celecoxib Sales Growth Rate (2015-2020) (K MT) Figure 69. Mexico Celecoxib Revenue Growth Rate (2015-2020) (US$ Million) Figure 70. Brazil Celecoxib Sales Growth Rate (2015-2020) (K MT) Figure 71. Brazil Celecoxib Revenue Growth Rate (2015-2020) (US$ Million) Figure 72. Argentina Celecoxib Sales Growth Rate (2015-2020) (K MT) Figure 73. Argentina Celecoxib Revenue Growth Rate (2015-2020) (US$ Million) Figure 74. Middle East and Africa Celecoxib Sales Market Share by Country in 2019 Figure 75. Middle East and Africa Celecoxib Revenue Market Share by Country in 2019 Figure 76. Turkey Celecoxib Sales Growth Rate (2015-2020) (K MT) Figure 77. Turkey Celecoxib Revenue Growth Rate (2015-2020) (US$ Million) Figure 78. Saudi Arabia Celecoxib Sales Growth Rate (2015-2020) (K MT) Figure 79. Saudi Arabia Celecoxib Revenue Growth Rate (2015-2020) (US$ Million) Figure 80. U.A.E Celecoxib Sales Growth Rate (2015-2020) (K MT) Figure 81. U.A.E Celecoxib Revenue Growth Rate (2015-2020) (US$ Million) Figure 82. Sales Market Share of Celecoxib by Type (2015-2020) Figure 83. Sales Market Share of Celecoxib by Type in 2019 Figure 84. Revenue Share of Celecoxib by Type (2015-2020) Figure 85. Revenue Market Share of Celecoxib by Type in 2019 Figure 86. Global Celecoxib Sales Growth by Type (2015-2020) (K MT) Figure 87. Global Celecoxib Sales Market Share by Application (2015-2020) Figure 88. Global Celecoxib Sales Market Share by Application in 2019 Figure 89. Global Revenue Share of Celecoxib by Application (2015-2020) Figure 90. Global Revenue Share of Celecoxib by Application in 2020 Figure 91. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018 Figure 92. Takeda Total Revenue (US$ Million): 2019 Compared with 2018 Figure 93. Teva Total Revenue (US$ Million): 2019 Compared with 2018 Figure 94. Mylan Total Revenue (US$ Million): 2019 Compared with 2018 Figure 95. Chengdu Suncadia Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 96. Jiangsu Chiatai Qingjiang Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018 Figure 97. Anhui Heyi Chemical Total Revenue (US$ Million): 2019 Compared with 2018 Figure 98. Price Trend of Key Raw Materials Figure 99. Manufacturing Cost Structure of Celecoxib Figure 100. Manufacturing Process Analysis of Celecoxib Figure 101. Celecoxib Industrial Chain Analysis Figure 102. Channels of Distribution Figure 103. Distributors Profiles Figure 104. Porter's Five Forces Analysis Figure 105. North America Celecoxib Sales (K MT) and Growth Rate Forecast (2021-2026) Figure 106. North America Celecoxib Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 107. Europe Celecoxib Sales (K MT) and Growth Rate Forecast (2021-2026) Figure 108. Europe Celecoxib Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 109. Latin America Celecoxib Sales (K MT) and Growth Rate Forecast (2021-2026) Figure 110. Latin America Celecoxib Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 111. Middle East and Africa Celecoxib Sales (K MT) and Growth Rate Forecast (2021-2026) Figure 112. Middle East and Africa Celecoxib Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 113. Asia Pacific Celecoxib Sales (K MT) and Growth Rate Forecast (2021-2026) Figure 114. Asia Pacific Celecoxib Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 115. Bottom-up and Top-down Approaches for This Report Figure 116. Data Triangulation Figure 117. Key Executives Interviewed

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

New Pharmaceuticals and Healthcare Reports

Other Reports by QY Research

Global Lithium Derivatives Market Research Report 2020

This report focuses on Lithium Derivatives volume and value at global level, regional level and company level. From a global perspective, this report represents overall Lithium Derivatives market size by analyzing historical data and future prospect....

Global Liquid Saturated Polyester Resin Market Research Report 2020

This report focuses on Liquid Saturated Polyester Resin volume and value at global level, regional level and company level. From a global perspective, this report represents overall Liquid Saturated Polyester Resin market size by analyzing historical...

Global Liquid Polybutadiene Market Research Report 2020

This report focuses on Liquid Polybutadiene volume and value at global level, regional level and company level. From a global perspective, this report represents overall Liquid Polybutadiene market size by analyzing historical data and future prospec...

Global Lidocaine Market Research Report 2020

This report focuses on Lidocaine volume and value at global level, regional level and company level. From a global perspective, this report represents overall Lidocaine market size by analyzing historical data and future prospect. Regionally, this re...

Global Leather Dyes Market Research Report 2020

This report focuses on Leather Dyes volume and value at global level, regional level and company level. From a global perspective, this report represents overall Leather Dyes market size by analyzing historical data and future prospect. Regionally, t...

Publisher: QY Research